GlucoTrack, Inc.

Stage 4 · Declining · week 45

As of Oct 22, 2026, GlucoTrack is in Stage 4, the downtrend phase, now in week 45 (since Dec 2, 2025). It closed at $0.60, 99.5% below its 52-week high and below its 200-day average, which is falling.

GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. More about the company

$0.60

-6.26% today

$609,588 · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is GCTK early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 19w

S1 14w

S4 45w

S4 46w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S4 19w → S1 14w → S2 13w → S3 9w → S2 9w → S3 2w → S4 45w → S1 9w → S4 46w current

Total tracked: 166 weeks across 9 stage runs.

GCTK among Medical Devices133rd of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
…133	GCTKGlucoTrack, Inc.	Stage 4 · wk 45	2	−70.5%

vs 52W High

-99.5%

$0.60 lo$109.50 hi

99.5% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 45

1w13w26w

Week 45, extended decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-95.5%

200 DMA: $13.35 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

0.08x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-70.5%

-86.3%

-94.5%

YTD

-99.0%

-99.4%

Scan Membership

Breakout Watch

Latest: 2024-09-09

5 appearances in last 60 days. First seen: 2019-08-30.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 45 · Vol 0.08x

2026-10-21S4

Wk 45 · Vol 0.04x

2026-10-20S4

Wk 45 · Vol 0.03x

2026-10-19S4

Wk 45 · Vol 0.06x

2026-10-16S4

Wk 44 · Vol 0.08x

2026-10-15S4

Wk 44 · Vol 0.08x

2026-10-14S4

Wk 44 · Vol 0.19x

2026-10-13S4

Wk 44 · Vol 0.09x

2026-10-12S4

Wk 44 · Vol 0.17x

2026-10-09S4

Wk 43 · Vol 0.10x

2026-10-08S4

Wk 43 · Vol 0.09x

2026-10-07S4

Wk 43 · Vol 0.04x

Moving averages & range

50 DMA

$2.67

200 DMA

$13.35

52W High

$109.50

52W Low

$0.60

5D Low

$0.60

Resistance levels (recent highs)

20d High

$1.82

60d High

$11.70

120d High

$12.90

250d High

$109.50

Next resistance

+203.8%

to 20d High

ROE

-620.6%

Profit margin 0.0%

Dividend Yield

0.00%

P/B -0.1

GlucoTrack: quick answers

What stage is GlucoTrack in?

As of Oct 22, 2026, GlucoTrack (GCTK) is in Stage 4, the downtrend phase. It entered Stage 4 on Dec 2, 2025 and is in week 45. What the four stages mean

Is GlucoTrack in an uptrend?

No. GlucoTrack is in a Stage 4 downtrend. It trades 95.5% below its 200-day average, which is falling.

How far is GlucoTrack from its 52-week high?

GlucoTrack closed at $0.60 on Oct 22, 2026, 99.5% below its 52-week high of $109.50. Its 52-week low is $0.60.

How has GlucoTrack performed over the past year?

As of Oct 22, 2026, GlucoTrack is down 99.4% over the past year and down 99.0% so far in 2026.

Which sector and industry is GlucoTrack in?

GlucoTrack is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.